{ "resourceType" : "PublicationRecord", "resourceDefinition" : "http://hl7.org/fhir/StructureDefinition/PublicationRecord|1.0.0-snapshot", "id" : "179625", "meta" : { "versionId" : "22", "lastUpdated" : "2026-06-26T20:08:00.255Z", "profile" : ["http://hl7.org/fhir/uv/ebm/StructureDefinition/journal-article-citation"] }, "language" : "en", "text" : { "status" : "extensions", "div" : "

Generated Narrative: PublicationRecord 179625

version: 22; Last updated: 2026-06-26 20:08:00+0000

Profile: JournalArticleCitation

ArtifactPublicationStatus: Active

url: https://fevir.net/resources/PublicationRecord/179625

identifier: FEvIR Object Identifier/179625, https://pubmed.ncbi.nlm.nih.gov/22502942

title: 22502942 Addition of radiotherapy to long-term androgen deprivation in locally advanced prostate cancer: an open randomised phase 3 trial.

status: Active

author: Computable Publishing®: MEDLINE-to-FEvIR Converter:

publisher: Computable Publishing LLC

contact: support@computablepublishing.com

description:

This Citation Resource is referenced in an example for the EBMonFHIR Implementation Guide.

\n

UseContexts

-CodeValue[x]
*Citation Classification Type: fevir-platform-use (FEvIR Platform Use)Medline Base

copyright:

Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse).

\n

approvalDate: 2012-12-07

lastReviewDate: 2022-03-10

classification

type: Citation Source

classifier: MEDLINE

classification

type: MEDLINE Citation Owner

classifier: National Library of Medicine, Index Section

currentState: Medline Citation Status of Medline, PubMed PublicationStatus of ppublish

statusDate

activity: PubMed Pubstatus of Received

period: ?? --> 2012-02-03

statusDate

activity: PubMed Pubstatus of Accepted

period: ?? --> 2012-03-23

statusDate

activity: PubMed Pubstatus of Entrez

period: ?? --> 2012-04-17 06:00:00+0000

statusDate

activity: PubMed Pubstatus of Pubmed

period: ?? --> 2012-04-17 06:00:00+0000

statusDate

activity: PubMed Pubstatus of Medline

period: ?? --> 2012-12-12 06:00:00+0000

citedArtifact

identifier: https://pubmed.ncbi.nlm.nih.gov/22502942, https://doi.org/10.1016/j.eururo.2012.03.053, pii/S0302-2838(12)00425-3

Titles

-TypeLanguageText
*Primary titleEnglish

Addition of radiotherapy to long-term androgen deprivation in locally advanced prostate cancer: an open randomised phase 3 trial.

\n

Abstracts

-TypeTextCopyright
*Primary human use

BACKGROUND: Radiotherapy combined with androgen-deprivation therapy (ADT) is superior to radiotherapy alone in localised prostate cancer; however, data comparing ADT alone are somewhat limited.\nOBJECTIVE: To compare 3-yr ADT plus radiotherapy with ADT alone in locally advanced prostate cancer patients.\nDESIGN, SETTING, AND PARTICIPANTS: A multicentre randomised open controlled phase 3 trial in 264 histologically confirmed T3-4 or pT3N0M0 prostate cancer patients randomised from March 2000 to December 2003.\nINTERVENTION: ADT (11.25mg subcutaneous depot injection of leuprorelin every 3 mo for 3 yr) plus external-beam radiotherapy or ADT alone. Flutamide (750 g/d) was administered for 1 mo.\nOUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The primary objective was 5 yr progression-free survival (PFS) according to clinical or biologic criteria, using the American Society for Therapeutic Radiology and Oncology (ASTRO) and the newer (Phoenix) definition (nadir plus 2 ng/ml), by intention to treat. Secondary objectives included time to locoregional recurrence and distant metastases, and overall and disease-specific survival. Our Analyses: intent-to-treat analysis, multivariate analyses using a Cox model with a 5% threshold from univariate analysis, and Kaplan-Meier estimates.\nRESULTS AND LIMITATIONS: ADT alone was administered to 130 patients and combined therapy to 133. With a median follow-up of 67 mo, 5-yr PFS was 60.9% for combined therapy versus 8.5% with ADT alone (ASTRO; p<0.0001), and 64.7% versus 15.4%, respectively, for Phoenix (p<0.0011). Locoregional progression was reported in 9.8% of combined-therapy patients versus 29.2% with ADT alone (p<0.0001) and metastatic progression in 3.0% versus 10.8%, respectively (p<0.018). Overall survival was 71.4% with combined therapy versus 71.5% with ADT alone; disease-specific survival was 93.2% versus 86.2%. Limitations included the relatively small population and a relatively short follow-up period.\nCONCLUSIONS: Combined therapy strongly favoured improved PFS, locoregional control, and metastasis-free survival. Longer follow-up is needed to assess the potential survival impact.

\n

Copyright © 2012 European Association of Urology. Published by Elsevier B.V. All rights reserved.

\n

RelatesTos

-TypeClassifierCitationTarget[x]
*Has Comment InComment

Eur Urol. 2012 Aug;62(2):220-1; author reply 222-3. doi: 10.1016/j.eururo.2012.04.040.

\n
https://pubmed.ncbi.nlm.nih.gov/22552217/

publicationForm

publishedIn

type: Periodical

identifier: Electronic ISSN Type/1873-7560, ISOAbbreviation/Eur Urol, ISSN Linking/0302-2838, Medline Title Abbreviation/Eur Urol, NLM Unique ID/7512719

title: European urology

publisherLocation: Switzerland

citedMedium: Internet

volume: 62

issue: 2

articleDate: 2012-08

publicationDateText: 2012-Aug

pageString: 213-9

publicationForm

citedMedium: Internet without issue

articleDate: 2012-04-03

webLocation

classifier: Abstract

url: https://pubmed.ncbi.nlm.nih.gov/22502942/

webLocation

classifier: DOI Based

url: https://doi.org/10.1016/j.eururo.2012.03.053

classification

type: Publishing Model

classifier: Print Electronic

classification

type: Chemical

classifier: Androgen Antagonists, Antineoplastic Agents, Hormonal, Flutamide, Prostate-Specific Antigen, Leuprolide

classification

type: MeSH heading

artifactAssessment: ArtifactAssessment: artifact[x] = this resource

classification

type: Publication type

classifier: Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't

classification

type: Knowledge Artifact Type

classifier: Journal Article

artifactAssessment: Classifier added by Computable Publishing LLC

classification

type: Citation subset

classifier: IM

contributorship

complete: true

entry

contributor: Mottet N

forenameInitials: N

affiliation: Department of Urology, University Hospital, St. Etienne, France. nicolas.mottet@wanadoo.fr

entry

contributor: Peneau M

forenameInitials: M

entry

contributor: Mazeron JJ

forenameInitials: JJ

entry

contributor: Molinie V

forenameInitials: V

entry

contributor: Richaud P

forenameInitials: P

Generated Narrative: Practitioner #contributor0

name: Nicolas Mottet

Generated Narrative: Practitioner #contributor1

name: Michel Peneau

Generated Narrative: Practitioner #contributor2

name: Jean-Jacques Mazeron

Generated Narrative: Practitioner #contributor3

name: Vincent Molinie

Generated Narrative: Practitioner #contributor4

name: Pierre Richaud

Generated Narrative: ArtifactAssessment #meshHeading0

artifact: PublicationRecord 22502942 Addition of radiotherapy to long-term androgen deprivation in locally advanced prostate cancer: an open randomised phase 3 trial.

content

type: components (if present) include qualifier codings

classifier: Adenocarcinoma

freeToShare: true

component

type: qualifier

classifier: is not a major topic

component

type: qualifier

classifier: drug therapy

Components

-TypeClassifier
*is Major topicNo

component

type: qualifier

classifier: radiotherapy

Components

-TypeClassifier
*is Major topicNo

component

type: qualifier

classifier: therapy

Components

-TypeClassifier
*is Major topicYes

content

type: components (if present) include qualifier codings

classifier: Aged

freeToShare: true

Components

-TypeClassifier
*qualifieris not a major topic

content

type: components (if present) include qualifier codings

classifier: Androgen Antagonists

freeToShare: true

component

type: qualifier

classifier: is not a major topic

component

type: qualifier

classifier: therapeutic use

Components

-TypeClassifier
*is Major topicNo

content

type: components (if present) include qualifier codings

classifier: Antineoplastic Agents, Hormonal

freeToShare: true

component

type: qualifier

classifier: is not a major topic

component

type: qualifier

classifier: therapeutic use

Components

-TypeClassifier
*is Major topicYes

content

type: components (if present) include qualifier codings

classifier: Chemoradiotherapy

freeToShare: true

Components

-TypeClassifier
*qualifieris not a major topic

content

type: components (if present) include qualifier codings

classifier: Disease-Free Survival

freeToShare: true

Components

-TypeClassifier
*qualifieris not a major topic

content

type: components (if present) include qualifier codings

classifier: Drug Therapy, Combination

freeToShare: true

Components

-TypeClassifier
*qualifieris not a major topic

content

type: components (if present) include qualifier codings

classifier: Flutamide

freeToShare: true

component

type: qualifier

classifier: is not a major topic

component

type: qualifier

classifier: therapeutic use

Components

-TypeClassifier
*is Major topicYes

content

type: components (if present) include qualifier codings

classifier: Humans

freeToShare: true

Components

-TypeClassifier
*qualifieris not a major topic

content

type: components (if present) include qualifier codings

classifier: Leuprolide

freeToShare: true

component

type: qualifier

classifier: is not a major topic

component

type: qualifier

classifier: therapeutic use

Components

-TypeClassifier
*is Major topicYes

content

type: components (if present) include qualifier codings

classifier: Male

freeToShare: true

Components

-TypeClassifier
*qualifieris not a major topic

content

type: components (if present) include qualifier codings

classifier: Middle Aged

freeToShare: true

Components

-TypeClassifier
*qualifieris not a major topic

content

type: components (if present) include qualifier codings

classifier: Neoplasm Grading

freeToShare: true

Components

-TypeClassifier
*qualifieris not a major topic

content

type: components (if present) include qualifier codings

classifier: Prostate-Specific Antigen

freeToShare: true

component

type: qualifier

classifier: is not a major topic

component

type: qualifier

classifier: blood

Components

-TypeClassifier
*is Major topicNo

content

type: components (if present) include qualifier codings

classifier: Prostatic Neoplasms

freeToShare: true

component

type: qualifier

classifier: is not a major topic

component

type: qualifier

classifier: drug therapy

Components

-TypeClassifier
*is Major topicNo

component

type: qualifier

classifier: radiotherapy

Components

-TypeClassifier
*is Major topicNo

component

type: qualifier

classifier: therapy

Components

-TypeClassifier
*is Major topicYes
" }, "contained" : [{ "resourceType" : "Practitioner", "id" : "contributor0", "name" : [{ "family" : "Mottet", "given" : ["Nicolas"] }] }, { "resourceType" : "Practitioner", "id" : "contributor1", "name" : [{ "family" : "Peneau", "given" : ["Michel"] }] }, { "resourceType" : "Practitioner", "id" : "contributor2", "name" : [{ "family" : "Mazeron", "given" : ["Jean-Jacques"] }] }, { "resourceType" : "Practitioner", "id" : "contributor3", "name" : [{ "family" : "Molinie", "given" : ["Vincent"] }] }, { "resourceType" : "Practitioner", "id" : "contributor4", "name" : [{ "family" : "Richaud", "given" : ["Pierre"] }] }, { "resourceType" : "ArtifactAssessment", "id" : "meshHeading0", "artifactReference" : { "reference" : "#", "type" : "PublicationRecord" }, "content" : [{ "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "code" : "mesh-heading", "display" : "MeSH heading" }], "text" : "components (if present) include qualifier codings" }, "classifier" : [{ "coding" : [{ "system" : "https://www.nlm.nih.gov/mesh", "code" : "D000230", "display" : "Adenocarcinoma", "userSelected" : false }] }], "freeToShare" : true, "component" : [{ "type" : { "text" : "qualifier" }, "classifier" : [{ "text" : "is not a major topic" }] }, { "type" : { "text" : "qualifier" }, "classifier" : [{ "coding" : [{ "system" : "https://www.nlm.nih.gov/mesh", "code" : "Q000188", "display" : "drug therapy" }] }], "component" : [{ "type" : { "text" : "is Major topic" }, "classifier" : [{ "coding" : [{ "system" : "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "code" : "C49487", "display" : "No" }] }] }] }, { "type" : { "text" : "qualifier" }, "classifier" : [{ "coding" : [{ "system" : "https://www.nlm.nih.gov/mesh", "code" : "Q000532", "display" : "radiotherapy" }] }], "component" : [{ "type" : { "text" : "is Major topic" }, "classifier" : [{ "coding" : [{ "system" : "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "code" : "C49487", "display" : "No" }] }] }] }, { "type" : { "text" : "qualifier" }, "classifier" : [{ "coding" : [{ "system" : "https://www.nlm.nih.gov/mesh", "code" : "Q000628", "display" : "therapy" }] }], "component" : [{ "type" : { "text" : "is Major topic" }, "classifier" : [{ "coding" : [{ "system" : "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "code" : "C49488", "display" : "Yes" }] }] }] }] }, { "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "code" : "mesh-heading", "display" : "MeSH heading" }], "text" : "components (if present) include qualifier codings" }, "classifier" : [{ "coding" : [{ "system" : "https://www.nlm.nih.gov/mesh", "code" : "D000368", "display" : "Aged", "userSelected" : false }] }], "freeToShare" : true, "component" : [{ "type" : { "text" : "qualifier" }, "classifier" : [{ "text" : "is not a major topic" }] }] }, { "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "code" : "mesh-heading", "display" : "MeSH heading" }], "text" : "components (if present) include qualifier codings" }, "classifier" : [{ "coding" : [{ "system" : "https://www.nlm.nih.gov/mesh", "code" : "D000726", "display" : "Androgen Antagonists", "userSelected" : false }] }], "freeToShare" : true, "component" : [{ "type" : { "text" : "qualifier" }, "classifier" : [{ "text" : "is not a major topic" }] }, { "type" : { "text" : "qualifier" }, "classifier" : [{ "coding" : [{ "system" : "https://www.nlm.nih.gov/mesh", "code" : "Q000627", "display" : "therapeutic use" }] }], "component" : [{ "type" : { "text" : "is Major topic" }, "classifier" : [{ "coding" : [{ "system" : "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "code" : "C49487", "display" : "No" }] }] }] }] }, { "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "code" : "mesh-heading", "display" : "MeSH heading" }], "text" : "components (if present) include qualifier codings" }, "classifier" : [{ "coding" : [{ "system" : "https://www.nlm.nih.gov/mesh", "code" : "D018931", "display" : "Antineoplastic Agents, Hormonal", "userSelected" : false }] }], "freeToShare" : true, "component" : [{ "type" : { "text" : "qualifier" }, "classifier" : [{ "text" : "is not a major topic" }] }, { "type" : { "text" : "qualifier" }, "classifier" : [{ "coding" : [{ "system" : "https://www.nlm.nih.gov/mesh", "code" : "Q000627", "display" : "therapeutic use" }] }], "component" : [{ "type" : { "text" : "is Major topic" }, "classifier" : [{ "coding" : [{ "system" : "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "code" : "C49488", "display" : "Yes" }] }] }] }] }, { "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "code" : "mesh-heading", "display" : "MeSH heading" }], "text" : "components (if present) include qualifier codings" }, "classifier" : [{ "coding" : [{ "system" : "https://www.nlm.nih.gov/mesh", "code" : "D059248", "display" : "Chemoradiotherapy", "userSelected" : false }] }], "freeToShare" : true, "component" : [{ "type" : { "text" : "qualifier" }, "classifier" : [{ "text" : "is not a major topic" }] }] }, { "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "code" : "mesh-heading", "display" : "MeSH heading" }], "text" : "components (if present) include qualifier codings" }, "classifier" : [{ "coding" : [{ "system" : "https://www.nlm.nih.gov/mesh", "code" : "D018572", "display" : "Disease-Free Survival", "userSelected" : false }] }], "freeToShare" : true, "component" : [{ "type" : { "text" : "qualifier" }, "classifier" : [{ "text" : "is not a major topic" }] }] }, { "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "code" : "mesh-heading", "display" : "MeSH heading" }], "text" : "components (if present) include qualifier codings" }, "classifier" : [{ "coding" : [{ "system" : "https://www.nlm.nih.gov/mesh", "code" : "D004359", "display" : "Drug Therapy, Combination", "userSelected" : false }] }], "freeToShare" : true, "component" : [{ "type" : { "text" : "qualifier" }, "classifier" : [{ "text" : "is not a major topic" }] }] }, { "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "code" : "mesh-heading", "display" : "MeSH heading" }], "text" : "components (if present) include qualifier codings" }, "classifier" : [{ "coding" : [{ "system" : "https://www.nlm.nih.gov/mesh", "code" : "D005485", "display" : "Flutamide", "userSelected" : false }] }], "freeToShare" : true, "component" : [{ "type" : { "text" : "qualifier" }, "classifier" : [{ "text" : "is not a major topic" }] }, { "type" : { "text" : "qualifier" }, "classifier" : [{ "coding" : [{ "system" : "https://www.nlm.nih.gov/mesh", "code" : "Q000627", "display" : "therapeutic use" }] }], "component" : [{ "type" : { "text" : "is Major topic" }, "classifier" : [{ "coding" : [{ "system" : "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "code" : "C49488", "display" : "Yes" }] }] }] }] }, { "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "code" : "mesh-heading", "display" : "MeSH heading" }], "text" : "components (if present) include qualifier codings" }, "classifier" : [{ "coding" : [{ "system" : "https://www.nlm.nih.gov/mesh", "code" : "D006801", "display" : "Humans", "userSelected" : false }] }], "freeToShare" : true, "component" : [{ "type" : { "text" : "qualifier" }, "classifier" : [{ "text" : "is not a major topic" }] }] }, { "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "code" : "mesh-heading", "display" : "MeSH heading" }], "text" : "components (if present) include qualifier codings" }, "classifier" : [{ "coding" : [{ "system" : "https://www.nlm.nih.gov/mesh", "code" : "D016729", "display" : "Leuprolide", "userSelected" : false }] }], "freeToShare" : true, "component" : [{ "type" : { "text" : "qualifier" }, "classifier" : [{ "text" : "is not a major topic" }] }, { "type" : { "text" : "qualifier" }, "classifier" : [{ "coding" : [{ "system" : "https://www.nlm.nih.gov/mesh", "code" : "Q000627", "display" : "therapeutic use" }] }], "component" : [{ "type" : { "text" : "is Major topic" }, "classifier" : [{ "coding" : [{ "system" : "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "code" : "C49488", "display" : "Yes" }] }] }] }] }, { "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "code" : "mesh-heading", "display" : "MeSH heading" }], "text" : "components (if present) include qualifier codings" }, "classifier" : [{ "coding" : [{ "system" : "https://www.nlm.nih.gov/mesh", "code" : "D008297", "display" : "Male", "userSelected" : false }] }], "freeToShare" : true, "component" : [{ "type" : { "text" : "qualifier" }, "classifier" : [{ "text" : "is not a major topic" }] }] }, { "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "code" : "mesh-heading", "display" : "MeSH heading" }], "text" : "components (if present) include qualifier codings" }, "classifier" : [{ "coding" : [{ "system" : "https://www.nlm.nih.gov/mesh", "code" : "D008875", "display" : "Middle Aged", "userSelected" : false }] }], "freeToShare" : true, "component" : [{ "type" : { "text" : "qualifier" }, "classifier" : [{ "text" : "is not a major topic" }] }] }, { "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "code" : "mesh-heading", "display" : "MeSH heading" }], "text" : "components (if present) include qualifier codings" }, "classifier" : [{ "coding" : [{ "system" : "https://www.nlm.nih.gov/mesh", "code" : "D060787", "display" : "Neoplasm Grading", "userSelected" : false }] }], "freeToShare" : true, "component" : [{ "type" : { "text" : "qualifier" }, "classifier" : [{ "text" : "is not a major topic" }] }] }, { "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "code" : "mesh-heading", "display" : "MeSH heading" }], "text" : "components (if present) include qualifier codings" }, "classifier" : [{ "coding" : [{ "system" : "https://www.nlm.nih.gov/mesh", "code" : "D017430", "display" : "Prostate-Specific Antigen", "userSelected" : false }] }], "freeToShare" : true, "component" : [{ "type" : { "text" : "qualifier" }, "classifier" : [{ "text" : "is not a major topic" }] }, { "type" : { "text" : "qualifier" }, "classifier" : [{ "coding" : [{ "system" : "https://www.nlm.nih.gov/mesh", "code" : "Q000097", "display" : "blood" }] }], "component" : [{ "type" : { "text" : "is Major topic" }, "classifier" : [{ "coding" : [{ "system" : "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "code" : "C49487", "display" : "No" }] }] }] }] }, { "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "code" : "mesh-heading", "display" : "MeSH heading" }], "text" : "components (if present) include qualifier codings" }, "classifier" : [{ "coding" : [{ "system" : "https://www.nlm.nih.gov/mesh", "code" : "D011471", "display" : "Prostatic Neoplasms", "userSelected" : false }] }], "freeToShare" : true, "component" : [{ "type" : { "text" : "qualifier" }, "classifier" : [{ "text" : "is not a major topic" }] }, { "type" : { "text" : "qualifier" }, "classifier" : [{ "coding" : [{ "system" : "https://www.nlm.nih.gov/mesh", "code" : "Q000188", "display" : "drug therapy" }] }], "component" : [{ "type" : { "text" : "is Major topic" }, "classifier" : [{ "coding" : [{ "system" : "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "code" : "C49487", "display" : "No" }] }] }] }, { "type" : { "text" : "qualifier" }, "classifier" : [{ "coding" : [{ "system" : "https://www.nlm.nih.gov/mesh", "code" : "Q000532", "display" : "radiotherapy" }] }], "component" : [{ "type" : { "text" : "is Major topic" }, "classifier" : [{ "coding" : [{ "system" : "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "code" : "C49487", "display" : "No" }] }] }] }, { "type" : { "text" : "qualifier" }, "classifier" : [{ "coding" : [{ "system" : "https://www.nlm.nih.gov/mesh", "code" : "Q000628", "display" : "therapy" }] }], "component" : [{ "type" : { "text" : "is Major topic" }, "classifier" : [{ "coding" : [{ "system" : "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "code" : "C49488", "display" : "Yes" }] }] }] }] }] }], "extension" : [{ "url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status", "valueCodeableConcept" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type", "code" : "active", "display" : "Active" }] } }], "url" : "https://fevir.net/resources/PublicationRecord/179625", "identifier" : [{ "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/v2-0203", "code" : "ACSN", "display" : "Accession ID" }], "text" : "FEvIR Object Identifier" }, "system" : "https://fevir.net/FOI", "value" : "179625", "assigner" : { "display" : "Computable Publishing LLC" } }, { "system" : "https://pubmed.ncbi.nlm.nih.gov", "value" : "22502942" }], "title" : "22502942 Addition of radiotherapy to long-term androgen deprivation in locally advanced prostate cancer: an open randomised phase 3 trial.", "status" : "active", "author" : [{ "name" : "Computable Publishing®: MEDLINE-to-FEvIR Converter" }], "publisher" : "Computable Publishing LLC", "contact" : [{ "telecom" : [{ "system" : "email", "value" : "support@computablepublishing.com" }] }], "description" : "This Citation Resource is referenced in an example for the EBMonFHIR Implementation Guide.", "useContext" : [{ "code" : { "system" : "http://terminology.hl7.org/CodeSystem/citation-classification-type", "code" : "fevir-platform-use", "display" : "FEvIR Platform Use" }, "valueCodeableConcept" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/citation-artifact-classifier", "code" : "medline-base", "display" : "Medline Base", "userSelected" : false }] } }], "copyright" : "Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse).", "approvalDate" : "2012-12-07", "lastReviewDate" : "2022-03-10", "classification" : [{ "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/citation-classification-type", "code" : "citation-source", "display" : "Citation Source" }] }, "classifier" : [{ "text" : "MEDLINE" }] }, { "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/citation-classification-type", "code" : "medline-owner", "display" : "MEDLINE Citation Owner" }] }, "classifier" : [{ "coding" : [{ "system" : "https://www.nlm.nih.gov/bsd/licensee/elements_descriptions.html#owner_value", "code" : "NLM", "display" : "National Library of Medicine, Index Section", "userSelected" : false }] }] }], "currentState" : [{ "coding" : [{ "system" : "http://hl7.org/fhir/uv/ebm-incubator/CodeSystem/publicationrecord-status-type", "code" : "medline-medline", "display" : "Medline Citation Status of Medline" }] }, { "coding" : [{ "system" : "http://hl7.org/fhir/uv/ebm-incubator/CodeSystem/publicationrecord-status-type", "code" : "pubmed-publication-status-ppublish", "display" : "PubMed PublicationStatus of ppublish" }] }], "statusDate" : [{ "activity" : { "coding" : [{ "system" : "http://hl7.org/fhir/uv/ebm-incubator/CodeSystem/publicationrecord-status-type", "code" : "pubmed-pubstatus-received", "display" : "PubMed Pubstatus of Received" }] }, "period" : { "end" : "2012-02-03" } }, { "activity" : { "coding" : [{ "system" : "http://hl7.org/fhir/uv/ebm-incubator/CodeSystem/publicationrecord-status-type", "code" : "pubmed-pubstatus-accepted", "display" : "PubMed Pubstatus of Accepted" }] }, "period" : { "end" : "2012-03-23" } }, { "activity" : { "coding" : [{ "system" : "http://hl7.org/fhir/uv/ebm-incubator/CodeSystem/publicationrecord-status-type", "code" : "pubmed-pubstatus-entrez", "display" : "PubMed Pubstatus of Entrez" }] }, "period" : { "end" : "2012-04-17T06:00:00.000Z" } }, { "activity" : { "coding" : [{ "system" : "http://hl7.org/fhir/uv/ebm-incubator/CodeSystem/publicationrecord-status-type", "code" : "pubmed-pubstatus-pubmed", "display" : "PubMed Pubstatus of Pubmed" }] }, "period" : { "end" : "2012-04-17T06:00:00.000Z" } }, { "activity" : { "coding" : [{ "system" : "http://hl7.org/fhir/uv/ebm-incubator/CodeSystem/publicationrecord-status-type", "code" : "pubmed-pubstatus-medline", "display" : "PubMed Pubstatus of Medline" }] }, "period" : { "end" : "2012-12-12T06:00:00.000Z" } }], "citedArtifact" : { "identifier" : [{ "system" : "https://pubmed.ncbi.nlm.nih.gov", "value" : "22502942" }, { "system" : "https://doi.org", "value" : "10.1016/j.eururo.2012.03.053" }, { "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/v2-0203", "code" : "ACSN", "display" : "Accession ID" }], "text" : "pii" }, "value" : "S0302-2838(12)00425-3" }], "title" : [{ "type" : [{ "coding" : [{ "system" : "http://hl7.org/fhir/title-type", "code" : "primary", "display" : "Primary title" }] }], "language" : "en", "text" : "Addition of radiotherapy to long-term androgen deprivation in locally advanced prostate cancer: an open randomised phase 3 trial." }], "abstract" : [{ "type" : [{ "coding" : [{ "system" : "http://hl7.org/fhir/cited-artifact-abstract-type", "code" : "primary-human-use", "display" : "Primary human use" }] }], "text" : "**BACKGROUND:** Radiotherapy combined with androgen-deprivation therapy (ADT) is superior to radiotherapy alone in localised prostate cancer; however, data comparing ADT alone are somewhat limited.\n**OBJECTIVE:** To compare 3-yr ADT plus radiotherapy with ADT alone in locally advanced prostate cancer patients.\n**DESIGN, SETTING, AND PARTICIPANTS:** A multicentre randomised open controlled phase 3 trial in 264 histologically confirmed T3-4 or pT3N0M0 prostate cancer patients randomised from March 2000 to December 2003.\n**INTERVENTION:** ADT (11.25mg subcutaneous depot injection of leuprorelin every 3 mo for 3 yr) plus external-beam radiotherapy or ADT alone. Flutamide (750 g/d) was administered for 1 mo.\n**OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS:** The primary objective was 5 yr progression-free survival (PFS) according to clinical or biologic criteria, using the American Society for Therapeutic Radiology and Oncology (ASTRO) and the newer (Phoenix) definition (nadir plus 2 ng/ml), by intention to treat. Secondary objectives included time to locoregional recurrence and distant metastases, and overall and disease-specific survival. Our Analyses: intent-to-treat analysis, multivariate analyses using a Cox model with a 5% threshold from univariate analysis, and Kaplan-Meier estimates.\n**RESULTS AND LIMITATIONS:** ADT alone was administered to 130 patients and combined therapy to 133. With a median follow-up of 67 mo, 5-yr PFS was 60.9% for combined therapy versus 8.5% with ADT alone (ASTRO; p<0.0001), and 64.7% versus 15.4%, respectively, for Phoenix (p<0.0011). Locoregional progression was reported in 9.8% of combined-therapy patients versus 29.2% with ADT alone (p<0.0001) and metastatic progression in 3.0% versus 10.8%, respectively (p<0.018). Overall survival was 71.4% with combined therapy versus 71.5% with ADT alone; disease-specific survival was 93.2% versus 86.2%. Limitations included the relatively small population and a relatively short follow-up period.\n**CONCLUSIONS:** Combined therapy strongly favoured improved PFS, locoregional control, and metastasis-free survival. Longer follow-up is needed to assess the potential survival impact.", "copyright" : "Copyright © 2012 European Association of Urology. Published by Elsevier B.V. All rights reserved." }], "relatesTo" : [{ "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/artifact-relationship-type", "code" : "comment-in", "display" : "Has Comment In" }] }, "classifier" : [{ "coding" : [{ "system" : "https://www.nlm.nih.gov/mesh", "code" : "D016420", "display" : "Comment", "userSelected" : false }] }], "citation" : "Eur Urol. 2012 Aug;62(2):220-1; author reply 222-3. doi: 10.1016/j.eururo.2012.04.040.", "targetUri" : "https://pubmed.ncbi.nlm.nih.gov/22552217/" }], "publicationForm" : [{ "publishedIn" : { "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/published-in-type", "code" : "D020492", "display" : "Periodical" }] }, "identifier" : [{ "type" : { "coding" : [{ "system" : "https://www.nlm.nih.gov/bsd/licensee/elements_descriptions.html#issn", "code" : "Electronic", "display" : "Electronic" }], "text" : "Electronic ISSN Type" }, "system" : "https://portal.issn.org", "value" : "1873-7560" }, { "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/v2-0203", "code" : "XX", "display" : "Organization identifier" }], "text" : "ISOAbbreviation" }, "system" : "https://www.issn.org/services/online-services/access-to-the-ltwa/", "value" : "Eur Urol" }, { "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/v2-0203", "code" : "XX", "display" : "Organization identifier" }], "text" : "ISSN Linking" }, "system" : "https://www.issn.org/understanding-the-issn/assignment-rules/the-issn-l-for-publications-on-multiple-media/", "value" : "0302-2838" }, { "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/v2-0203", "code" : "XX", "display" : "Organization identifier" }], "text" : "Medline Title Abbreviation" }, "system" : "https://www.nlm.nih.gov/tsd/cataloging/contructitleabbre.html", "value" : "Eur Urol" }, { "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/v2-0203", "code" : "XX", "display" : "Organization identifier" }], "text" : "NLM Unique ID" }, "system" : "https://locatorplus.gov/cgi-bin/Pwebrecon.cgi?DB=local", "value" : "7512719" }], "title" : "European urology", "publisherLocation" : "Switzerland" }, "citedMedium" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/cited-medium", "code" : "internet", "display" : "Internet" }] }, "volume" : "62", "issue" : "2", "articleDate" : "2012-08", "publicationDateText" : "2012-Aug", "pageString" : "213-9" }, { "citedMedium" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/cited-medium", "code" : "internet-without-issue", "display" : "Internet without issue" }] }, "articleDate" : "2012-04-03" }], "webLocation" : [{ "classifier" : [{ "coding" : [{ "system" : "http://hl7.org/fhir/artifact-url-classifier", "code" : "abstract", "display" : "Abstract" }] }], "url" : "https://pubmed.ncbi.nlm.nih.gov/22502942/" }, { "classifier" : [{ "coding" : [{ "system" : "http://hl7.org/fhir/artifact-url-classifier", "code" : "doi-based", "display" : "DOI Based" }] }], "url" : "https://doi.org/10.1016/j.eururo.2012.03.053" }], "classification" : [{ "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "code" : "publishing-model", "display" : "Publishing Model", "userSelected" : false }] }, "classifier" : [{ "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/citation-artifact-classifier", "code" : "Print-Electronic", "display" : "Print Electronic", "userSelected" : false }] }] }, { "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "code" : "chemical", "display" : "Chemical", "userSelected" : false }] }, "classifier" : [{ "coding" : [{ "system" : "https://www.nlm.nih.gov/mesh", "code" : "D000726", "display" : "Androgen Antagonists", "userSelected" : false }] }, { "coding" : [{ "system" : "https://www.nlm.nih.gov/mesh", "code" : "D018931", "display" : "Antineoplastic Agents, Hormonal", "userSelected" : false }] }, { "coding" : [{ "system" : "https://www.cas.org/support/documentation/chemical-substances", "code" : "76W6J0943E", "userSelected" : false }, { "system" : "https://www.nlm.nih.gov/mesh", "code" : "D005485", "display" : "Flutamide", "userSelected" : false }] }, { "coding" : [{ "system" : "https://www.cas.org/support/documentation/chemical-substances", "code" : "EC 3.4.21.77", "userSelected" : false }, { "system" : "https://www.nlm.nih.gov/mesh", "code" : "D017430", "display" : "Prostate-Specific Antigen", "userSelected" : false }] }, { "coding" : [{ "system" : "https://www.cas.org/support/documentation/chemical-substances", "code" : "EFY6W0M8TG", "userSelected" : false }, { "system" : "https://www.nlm.nih.gov/mesh", "code" : "D016729", "display" : "Leuprolide", "userSelected" : false }] }] }, { "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "code" : "mesh-heading", "display" : "MeSH heading" }] }, "artifactAssessment" : [{ "reference" : "#meshHeading0", "type" : "ArtifactAssessment" }] }, { "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "code" : "publication-type", "display" : "Publication type" }] }, "classifier" : [{ "coding" : [{ "system" : "https://www.nlm.nih.gov/mesh", "code" : "D017428", "display" : "Clinical Trial, Phase III", "userSelected" : false }] }, { "coding" : [{ "system" : "https://www.nlm.nih.gov/mesh", "code" : "D016428", "display" : "Journal Article", "userSelected" : false }] }, { "coding" : [{ "system" : "https://www.nlm.nih.gov/mesh", "code" : "D016448", "display" : "Multicenter Study", "userSelected" : false }] }, { "coding" : [{ "system" : "https://www.nlm.nih.gov/mesh", "code" : "D016449", "display" : "Randomized Controlled Trial", "userSelected" : false }] }, { "coding" : [{ "system" : "https://www.nlm.nih.gov/mesh", "code" : "D013485", "display" : "Research Support, Non-U.S. Gov't", "userSelected" : false }] }] }, { "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "code" : "knowledge-artifact-type", "display" : "Knowledge Artifact Type", "userSelected" : false }] }, "classifier" : [{ "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/citation-artifact-classifier", "code" : "D016428", "display" : "Journal Article", "userSelected" : false }] }], "artifactAssessment" : [{ "display" : "Classifier added by Computable Publishing LLC" }] }, { "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "code" : "citation-subset", "display" : "Citation subset", "userSelected" : false }] }, "classifier" : [{ "coding" : [{ "system" : "https://www.nlm.nih.gov/bsd/licensee/elements_descriptions.html#citationsubset", "code" : "IM", "display" : "IM", "userSelected" : false }] }] }], "contributorship" : { "complete" : true, "entry" : [{ "contributor" : { "reference" : "#contributor0", "type" : "Practitioner", "display" : "Mottet N" }, "forenameInitials" : "N", "affiliation" : [{ "display" : "Department of Urology, University Hospital, St. Etienne, France. nicolas.mottet@wanadoo.fr" }] }, { "contributor" : { "reference" : "#contributor1", "type" : "Practitioner", "display" : "Peneau M" }, "forenameInitials" : "M" }, { "contributor" : { "reference" : "#contributor2", "type" : "Practitioner", "display" : "Mazeron JJ" }, "forenameInitials" : "JJ" }, { "contributor" : { "reference" : "#contributor3", "type" : "Practitioner", "display" : "Molinie V" }, "forenameInitials" : "V" }, { "contributor" : { "reference" : "#contributor4", "type" : "Practitioner", "display" : "Richaud P" }, "forenameInitials" : "P" }] } } }